| Views | |
|---|---|
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial | 409 |
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | |
|---|---|---|---|---|---|---|---|
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial | 59 | 9 | 9 | 3 | 6 | 9 | 1 |
| Views |
|---|
| Views | |
|---|---|
| Russia | 143 |
| Views | |
|---|---|
| Kazan | 143 |